| Model Number |
RONYX22515UX |
| Medical Device Problem Codes |
Detachment of Device or Device Component (2907); Device Dislodged or Dislocated (2923); Material Deformation (2976)
|
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
| Date of Event |
03/02/2020
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
During a procedure an attempt was made to use one resolute onyx rx coronary drug eluting stent to treat a lesion located in the circumflex (cx) artery.The device was inspected with no issues noted.Negative prep was performed with no issues noted.The lesion was pre-dilated.Resistance was not encountered when advancing the device.Excessive force was not used during delivery.It was reported that the balloon component detached, cracked or fractured during removal of the device.It was stated the physician removed the device so they could return again and deploy the stent, however the stent was detached outside the patient before they could redeploy.The procedure was completed using another resolute onyx stent.The patient was reported to be alive with no injuries.
|
| |
|
Additional Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Additional Manufacturer Narrative
|
|
Product analysis summary: there was no detachment evident to the delivery system.The stent was not present on the balloon.Balloon folds were expanded, and contrast was visible in the balloon.Crimp impressions were evident on the balloon surface.Deformation was evident to most of the dislodged stent, with stretching and twisting evident to struts.It was unclear if it was the proximal struts or the distal struts that remained intact.The inner lumen patency could not be verified with a 0.015 inch mandrel, most likely due to hardened blood in the guidewire lumen.No deformation was evident to the distal tip.No other deformation was evident.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Search Alerts/Recalls
|